The impact of Nemagon in the working population in Costa Rica

DBCP known by the brand name Nemagon, created to combat nematodes that damaged the banana crop, was created in the laboratories of Dow Chemical Company and Shell Chemical Company. The first tests were conducted, showed in rat’s older lesions in the lungs, liver and kidneys, reduced growth retarded and testicles. Food and Drug Administration (FDA) of USA registration of DBCP in 1961, the report included recommendations for use and precautions then excluded on the labels. Indicating the same could be used without undue risk, registered in 1964.   1969, Standard Fruit Company began its use in banana plantations in Central America in their manuals are not indicated on its danger and never given protective gear.   1975, the Environmental Protection Agency United States ended the DBCP was a possible carcinogen. In the U.S.  DBCP is considered to cause male sterility, a strong genetic toxicity and is a cacogenic agent, mutagen aneuploidógeno. Included in the EPA group B2, probable human carcinogen.   Costa Rica in 1968 and 1979, thousands of banana workers in the Atlantic and the Southern injected about 5 million gallons of DBCP, without gloves, protective clothing or equipment of any.   Women and children entering the areas of application for taking lunch direct exposure to vapours, women washed clothes impregnated directly DBCP, an estimated 30 000 people were affected by the contact.   Law Act No. 8130 known as "Social and Economic Benefits Compensation for the affected population" DBCP “signed in San Jose, August 27, 2011 and entry into force, on 06 September that year.   This population began its work in the banana plantations at an early age, illiterate with problems of excess consumption of licit and illicit. Seniors currently with poor socioeconomic status. Affectation sociocultural conditions that provoked Nemagon use in this population in Costa Rica.